Suggestion de sujets dans votre recherche.
Résultat(s) 1 - 20 résultats de 69 pour la requête '"15C2VL427D"', Temps de recherche: 3,17s Affiner les résultats
  1. 1
    Outcomes of Intravitreal Aflibercept 8 mg in Eyes With Neovascular Age-Related Macular Degeneration Previously Treated With Faricimab
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  2. 2
    Simultaneous Intravitreal Steroid and Anti-VEGF Therapy for Monotherapy-Resistant Chronic Wet Age-Related Macular Degeneration
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  3. 3
    Complications, Compliance, and 3-Year Outcomes After Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  4. 4
    Reply to Letter to the Editor Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  5. 5
    Endolaserless Vitrectomy With Aflibercept Monotherapy for Proliferative Diabetic Retinopathy-Related Vitreous Hemorrhage
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  6. 6
    Antiangiogenic Nanomicelles for the Topical Delivery of Aflibercept to Treat Retinal Neovascular Disease
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  7. 7
    Aflibercept for Retinopathy of Prematurity A Systematic Review and Meta-Analysis
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  8. 8
    Clinical Outcomes of Eyes With Diabetic Macular Edema Switched From Aflibercept to Ranibizumab Therapy
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  9. 9
    Macular Atrophy Affecting Visual Outcomes in Patients Undergoing Anti-VEGF Treatment in Routine Clinical Practice
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  10. 10
    Prevention of Macular Edema in Patients With Diabetic Retinopathy Undergoing Cataract Surgery The PROMISE Trial
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  11. 11
    Intravitreal Ziv-Aflibercept in Patients With Diabetic Macular Edema Refractory to Intravitreal Bevacizumab
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  12. 12
    Twenty-Four-Month OCTA Assessment in Diabetic Patients Undergoing Fixed-Interval Intravitreal Aflibercept Therapy
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  13. 13
    Impact of Systemic Dipeptidyl Peptidase-4 Inhibitor Use in Diabetic Macular Edema
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  14. 14
    Correlation of Macular Thickness and Visual Acuity in DME Treated by Two Doses of Intravitreal Ziv-Aflibercept Versus Bevacizumab Analysis of a Randomized, Three-Armed Clinical Trial
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  15. 15
    Quarterly Anti-Vascular Endothelial Growth Factor Dosing for Neovascular Age-Related Macular Degeneration Real-World Clinical Outcomes
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  16. 16
    Intraoperative Drainage of a Bullous Serous Pigment Epithelial Detachment
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  17. 17
    Inflammatory Reaction After Aflibercept Intravitreal Injections Associated With Silicone Oil Droplets Released From Syringes A Case-Control Study
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  18. 18
    Classification of Strokes in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  19. 19
    Bilateral Choroidal Osteoma Complicated by Bilateral Choroidal Neovascularization
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

  20. 20
    Loss to Follow-Up in Patients With Retinal Vein Occlusion Undergoing Intravitreal Anti-VEGF Injections
    Sujets: “...NLM 15C2VL427D...”

    Article en ligne

Outils de recherche: S'abonner aux flux RSS — Envoyer cette recherche par courriel